Key Updates
Berkshire Hathaway shares rebounded 2.04% to $722,500 since the January 28 report, partially recovering from recent declines though YTD losses remain at -4.28%. The period featured completion of the $9.7 billion OxyChem acquisition, marking Berkshire's largest deployment of capital since 2022 and demonstrating new CEO Greg Abel's commitment to executing strategic transactions. This positive development contrasts with ongoing concerns about the potential Kraft Heinz divestiture, which continues to weigh on investor sentiment regarding portfolio management under new leadership. The acquisition adds a leading chemical manufacturer to Berkshire's industrial portfolio, diversifying revenue streams across water treatment, pharmaceuticals, and construction sectors.
Current Trend
Berkshire shares have declined 4.28% YTD to $722,500, underperforming the broader market as investors assess the post-Buffett transition. The stock showed recent strength with gains of 1.19% over one day and 0.22% over five days, suggesting stabilization after the 4.28% monthly decline. Over six months, shares are up 1.17%, indicating modest positive momentum in the medium term. The recent 2.04% gain since the last report reflects positive market reaction to the completed OxyChem acquisition. Key resistance levels remain near the $740,000-750,000 range established in late 2025, while support has formed around $700,000-708,000 based on recent trading patterns.
Investment Thesis
The investment thesis centers on Berkshire's ability to deploy its record $381.6 billion cash position into value-accretive acquisitions and investments under new CEO Greg Abel's leadership. The OxyChem acquisition demonstrates Abel's willingness to execute large-scale transactions, addressing concerns about capital deployment that emerged during Buffett's final year. The conglomerate's diversified business model spanning insurance, utilities, rail, manufacturing, and retail provides defensive characteristics and multiple earnings streams. However, the thesis faces headwinds from underperformance versus the S&P 500, potential dilution of Buffett's voting control as he donates his wealth, and uncertainty around the Kraft Heinz stake disposition. The company's $1 trillion market capitalization and portfolio of wholly-owned businesses provide stability, while the massive cash position offers optionality for opportunistic investments or shareholder returns.
Thesis Status
The investment thesis is showing early signs of validation with the OxyChem acquisition completion, marking Abel's first major capital deployment as CEO. This $9.7 billion transaction directly addresses previous concerns about Berkshire's inability to find suitable acquisition targets at reasonable valuations. However, the thesis remains under pressure from the YTD underperformance and ongoing Kraft Heinz divestiture uncertainty, which signals potential portfolio restructuring that could create near-term volatility. The formation of a technical "golden cross" pattern provides modest support for improved momentum, though historical precedent suggests this may take time to materialize into sustained outperformance. The cash position remains elevated at $381.6 billion, indicating significant deployment opportunities remain, but also highlighting the challenge of finding attractive investments at scale in current market conditions.
Key Drivers
The completed $9.7 billion OxyChem acquisition represents the primary positive catalyst, expanding Berkshire's chemical manufacturing capabilities and adding a top-three U.S. producer of polyvinyl chloride and chlor-alkali products. This transaction, Berkshire's largest since the $11.6 billion Alleghany deal in 2022, demonstrates Abel's commitment to deploying capital into industrial businesses with established market positions. The potential exit from the 28% Kraft Heinz stake continues to create uncertainty, with the food company's planned split into two entities adding complexity to the divestiture timeline. Buffett's pledge to donate 99% of his $148 billion Berkshire stake within 10 years of estate settlement raises long-term governance concerns about potential shareholder activism once voting control becomes diluted. The bullish "golden cross" technical pattern formed in early 2026 historically preceded average gains of 30% in Berkshire shares, though past performance provides no guarantees.
Technical Analysis
Berkshire shares are trading at $722,500, establishing a recovery pattern after testing support near $708,000 in late January. The stock formed a bullish "golden cross" in early 2026 with the 50-day moving average crossing above the 200-day moving average, a pattern that historically preceded significant gains. Immediate resistance exists at $740,000-750,000, representing levels from late 2025 trading. Support has solidified around $700,000-708,000 based on recent price action. Short-term momentum indicators show improvement with the 1-day gain of 1.19% and 5-day gain of 0.22%, though the 1-month decline of 4.28% indicates ongoing consolidation. The 6-month gain of 1.17% suggests a gradual uptrend in the medium term, while YTD performance of -4.28% reflects the market's cautious stance on the leadership transition. Volume and volatility patterns remain consistent with Berkshire's historically stable trading characteristics.
Bull Case
- Strategic Capital Deployment Through OxyChem Acquisition: The completed $9.7 billion OxyChem acquisition demonstrates Greg Abel's ability to execute meaningful transactions, adding a top-three U.S. chemical producer with diversified end markets including water treatment, pharmaceuticals, and construction, directly addressing concerns about capital deployment.
- Record Cash Position Provides Deployment Optionality: Berkshire's $381.6 billion cash reserve offers substantial firepower for opportunistic acquisitions or increased shareholder returns, with Abel expressing willingness to deploy up to $100 billion on suitable transactions.
- Bullish Technical Pattern Formation: The "golden cross" technical pattern historically preceded average gains of approximately 30% in Berkshire shares over the past 25 years, with 14 previous occurrences supporting positive momentum.
- Diversified Business Model Provides Stability: The conglomerate's portfolio spanning insurance, utilities, rail, manufacturing, and retail creates multiple revenue streams and defensive characteristics that reduce dependence on any single sector.
- Century-Long Durability Endorsed by Buffett: Buffett's assessment that Berkshire has the best odds of any company to last a century and his strong endorsement of Greg Abel provide confidence in the company's long-term structural advantages and governance framework.
Bear Case
- Portfolio Restructuring Uncertainty from Kraft Heinz Exit: The potential sale of the entire 28% Kraft Heinz stake representing 325.6 million shares creates near-term overhang, with the position down approximately 70% since the 2015 merger and a $3.8 billion writedown taken last year.
- Future Governance Vulnerability from Buffett's Wealth Donation: Buffett's plan to donate his $148 billion stake within 10 years could dilute voting control and expose Berkshire to shareholder activism for the first time in six decades, potentially pressuring capital allocation decisions.
- Persistent Underperformance Versus Market Benchmarks: Berkshire shares gained 10.9% in 2025 versus the S&P 500's 16.4% rise, and the YTD decline of 4.28% suggests the market remains cautious about Abel's ability to maintain the premium valuation commanded under Buffett.
- Limited Acquisition Opportunities at Reasonable Valuations: Despite expressing willingness to deploy up to $100 billion, Buffett found no suitable large-scale opportunities throughout 2025, indicating structural challenges in finding attractively priced targets in current market conditions.
- Major Portfolio Reduction Creates Reinvestment Risk: Berkshire significantly reduced positions in Apple and Bank of America, with the equity portfolio declining to $283.2 billion by September 30, raising questions about Abel's ability to redeploy proceeds into comparable quality investments.